Thomas Koch

8.0k total citations · 1 hit paper
112 papers, 6.3k citations indexed

About

Thomas Koch is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Thomas Koch has authored 112 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 38 papers in Cellular and Molecular Neuroscience and 19 papers in Physiology. Recurrent topics in Thomas Koch's work include Receptor Mechanisms and Signaling (36 papers), Neuropeptides and Animal Physiology (33 papers) and Pharmacological Receptor Mechanisms and Effects (15 papers). Thomas Koch is often cited by papers focused on Receptor Mechanisms and Signaling (36 papers), Neuropeptides and Animal Physiology (33 papers) and Pharmacological Receptor Mechanisms and Effects (15 papers). Thomas Koch collaborates with scholars based in Germany, United States and Switzerland. Thomas Koch's co-authors include Volker Höllt, Stefan Schulz, Helmut Schröder, Manuela Pfeiffer, A. James Barkovich, B. O. Berg, Jacqueline Trotter, Lars‐Ove Brandenburg, Mark von Zastrow and Charles Chavkin and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Thomas Koch

110 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

2013 624 citations Stefan Schulz, Thomas Koch et al. profile →

Peers

Countries citing papers authored by Thomas Koch

Since Specialization

Citations

This map shows the geographic impact of Thomas Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Koch more than expected).

Fields of papers citing papers by Thomas Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Koch. The network helps show where Thomas Koch may publish in the future.

Co-authorship network of co-authors of Thomas Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Koch. A scholar is included among the top collaborators of Thomas Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Koch. Thomas Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurocognitive Performance, Vestibulo-Ocular Function and Postural Control in Youth Male Soccer and Basketball Players of Different Ages 2024 ·(unknown), (unknown), Thomas Koch, (unknown), (unknown)	1
2	Improvement of transitional care from hospital to home for older patients, the TIGER study: protocol of a randomised controlled trial 2021 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), (unknown), Dirk van den Heuvel, (unknown), Thomas Koch, Oliver Schoeffski, Dorothee Volkert, Katja Wingenfeld, Susanne Wurm, Ellen Freiberger, Cornel Sieber	10
3	Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors 2019 ·Handbook of experimental pharmacology ·Thomas Tzschentke, Klaus Linz, Thomas Koch, Thomas Christoph	24
4	Complementary and Conventional Medicine Use Among Youth with Recurrent Headaches 2014 ·The Journal of Alternative and Complementary Medicine ·Christina Bethell, Kathi J. Kemper, Narangerel Gombojav, Thomas Koch	2
5	Diagnostic Testing and Treatment of Pediatric Headache in the Emergency Department 2013 ·The Journal of Pediatrics ·David C. Sheridan, Garth Meckler, David M. Spiro, Thomas Koch, Matthew Hansen	37
6	Analgesic Tolerance to High-Efficacy Agonists But Not to Morphine Is Diminished in Phosphorylation-Deficient S375A μ-Opioid Receptor Knock-In Mice 2011 ·Journal of Neuroscience ·Gisela Grecksch, (unknown), (unknown), (unknown), Laura Glück, Christian Doll, Amelie Lupp, Axel Becker, Thomas Koch, Ralf Stumm, Volker Höllt, Stefan Schulz	49
7	Functional and physical interactions between formyl‐peptide‐receptors and scavenger receptor MARCO and their involvement in amyloid beta 1–42‐induced signal transduction in glial cells 2010 ·Journal of Neurochemistry ·Lars‐Ove Brandenburg, (unknown), Christoph Jan Wruck, Thomas Koch, Ralph Lucius, Thomas Pufe	65
8	Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29 2009 ·Molecular Membrane Biology ·Lars‐Ove Brandenburg, (unknown), Christoph Jan Wruck, Thomas Koch, Philip Rosenstiel, Ralph Lucius, Thomas Pufe, (unknown)	13
9	ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2 2009 ·Cellular Signalling ·M. Ranković, (unknown), Vladan Rankovic, Lars‐Ove Brandenburg, Helmut Schröder, Volker Höllt, Thomas Koch	28
10	Role of receptor internalization in opioid tolerance and dependence 2007 ·Pharmacology & Therapeutics ·Thomas Koch, Volker Höllt	151
11	Submersion and asphyxial injury 2002 ·Critical Care Medicine ·Laura M. Ibsen, Thomas Koch	66
12	Carboxyl-terminal Splicing of the Rat μ Opioid Receptor Modulates Agonist-mediated Internalization and Receptor Resensitization 1998 ·Journal of Biological Chemistry ·Thomas Koch, Stefan Schulz, (unknown), Ronald Wolf, (unknown), (unknown)	174
13	Oligodendrocytes Direct Glycosyl Phosphatidylinositol-anchored Proteins to the Myelin Sheath in Glycosphingolipid-rich Complexes 1997 ·Journal of Biological Chemistry ·Eva‐Maria Krämer‐Albers, Thomas Koch, Antje Niehaus, Jacqueline Trotter	109
14	Dermatitis in treated maple syrup urine disease 1993 ·Journal of the American Academy of Dermatology ·Susan E. Koch, Seymour Packman, Thomas Koch, Mary L. Williams	21
15	MR imaging of fat-containing tissues: Valuation of two quantitative imaging techniques in comparison with localized proton spectroscopy 1993 ·Magnetic Resonance Imaging ·Gunnar Brix, Sabine Heiland, Matthias E. Bellemann, Thomas Koch, Walter J. Lorenz	86
16	In vivo¹H, ³¹P‐{¹H} and ¹³C‐{¹H} magnetic resonance spectroscopy of malignant histiocytoma and skeletal muscle tissue in man 1992 ·NMR in Biomedicine ·Peter Bachert, Matthias E. Bellemann, G. Layer, Thomas Koch, Wolfhard Semmler, Walter J. Lorenz	17
17	Binding sites of atrial natriuretic peptide (ANP) in the mammalian cochlea and stimulation of cyclic GMP synthesis 1992 ·Hearing Research ·Thomas Koch, B. Gloddek, (unknown)	18
18	MR Imaging of Intracranial Tuberous Sclerosis 1987 ·American Journal of Neuroradiology ·(unknown), Sheila Moore, Michael Brant‐Zawadzki, Bruce O. Berg, Thomas Koch, Thomas H. Newton, Michael S. B. Edwards	4
19	Posterior fossa hemorrhage in term newborns 1985 ·Pediatric Neurology ·Thomas Koch, (unknown), Michael S. B. Edwards, Suzanne L. Davis	11
20	Variability of serial CT scans in subacute necrotizing encephalomyelopathy (leigh disease) 1985 ·Pediatric Neurology ·Thomas Koch, Warren Lo, Bruce O. Berg	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact